Literature DB >> 11953328

Helicobacter and gastric MALT lymphoma.

M Stolte1, E Bayerdörffer, A Morgner, B Alpen, T Wündisch, C Thiede, A Neubauer.   

Abstract

Helicobacter pylori infection is a pre-MALT lymphoma condition. H pylori eradication leads to complete remission in 80% of low grade stage E1 lymphomas, with a yearly recurrence rate of approximately 5%. The possibility for complete remission in high grade lymphomas needs to be investigated in prospective studies. In addition, the significance of persistent B cell monoclonality (stable disease? danger of relapse? regression of monoclonality?) needs to be investigated in follow up studies.

Entities:  

Mesh：

Year:  2002        PMID： 11953328      PMCID： PMC1867678          DOI： 10.1136/gut.50.suppl_3.iii19

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  59 in total

1.  The sarcomas of the stomach: a review with reference to gross pathology and gastroscopic manifestations.

Authors:  E D PALMER
Journal:  Am J Dig Dis       Date:  1950-06

2.  A clinicopathologic study of gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  S Ohashi; K Segawa; S Okamura; H Urano; S Kanamori; H Ishikawa; K Hara; A Hukutomi; K Shirai; M Maeda
Journal:  Cancer       Date:  2000-05-15       Impact factor: 6.860

3.  Eradication of Helicobacter pylori and stability of remissions in low-grade gastric B-cell lymphomas of the mucosa-associated lymphoid tissue: results of an ongoing multicenter trial.

Authors:  C Thiede; T Wündisch; B Neubauer; B Alpen; A Morgner; M Ritter; G Ehninger; M Stolte; E Bayerdörffer; A Neubauer
Journal:  Recent Results Cancer Res       Date:  2000

Review 4.  Gastric MALT lymphoma and its relationship to Helicobacter pylori infection: management and pathogenesis of the disease.

Authors:  A Morgner; E Bayerdörffer; A Neubauer; M Stolte
Journal:  Microsc Res Tech       Date:  2000-03-15       Impact factor: 2.769

5.  Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group.

Authors:  W Fischbach; B Dragosics; M E Kolve-Goebeler; C Ohmann; A Greiner; Q Yang; S Böhm; P Verreet; O Horstmann; M Busch; E Dühmke; H K Müller-Hermelink; K Wilms; S Allinger; P Bauer; S Bauer; A Bender; G Brandstätter; A Chott; C Dittrich; K Erhart; D Eysselt; H Ellersdorfer; A Ferlitsch; M A Fridrik; A Gartner; M Hausmaninger; W Hinterberger; K Hügel; P Ilsinger; K Jonaus; G Judmaier; J Karner; E Kerstan; P Knoflach; K Lenz; A Kandutsch; M Lobmeyer; H Michlmeier; H Mach; C Marosi; W Ohlinger; H Oprean; H Pointer; J Pont; H Salabon; H J Samec; A Ulsperger; A Wimmer; F Wewalka
Journal:  Gastroenterology       Date:  2000-11       Impact factor: 22.682

6.  Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy.

Authors:  H Liu; A Ruskon-Fourmestraux; A Lavergne-Slove; H Ye; T Molina; Y Bouhnik; R A Hamoudi; T C Diss; A Dogan; F Megraud; J C Rambaud; M Q Du; P G Isaacson
Journal:  Lancet       Date:  2001-01-06       Impact factor: 79.321

7.  Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.

Authors:  A Ruskoné-Fourmestraux; A Lavergne; P H Aegerter; F Megraud; L Palazzo; A de Mascarel; T Molina; J L Rambaud
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

8.  Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection.

Authors:  A Morgner; S Miehlke; W Fischbach; W Schmitt; H Müller-Hermelink; A Greiner; C Thiede; J Schetelig; A Neubauer; M Stolte; G Ehninger; E Bayerdörffer
Journal:  J Clin Oncol       Date:  2001-04-01       Impact factor: 44.544

9.  Early lymphoma coexisting with reactive lymphoid hyperplasia of the stomach.

Authors:  H Murayama; M Kikuchi; T Eimoto; T Doki; K Doki
Journal:  Acta Pathol Jpn       Date:  1984-05

10.  Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma.

Authors:  P Isaacson; D H Wright
Journal:  Cancer       Date:  1983-10-15       Impact factor: 6.860
View more
  68 in total

1.  Phosphatidylethanolamine of Helicobacter pylori functions as a steroid-binding lipid in the assimilation of free cholesterol and 3β-hydroxl steroids into the bacterial cell membrane.

Authors:  Hirofumi Shimomura; Kouichi Hosoda; Shunji Hayashi; Kenji Yokota; Yoshikazu Hirai
Journal:  J Bacteriol       Date:  2012-03-09       Impact factor: 3.490

Review 2.  Therapy of non-Hodgkin's lymphoma.

Authors:  J Coffey; D C Hodgson; M K Gospodarowicz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-12       Impact factor: 9.236

3.  Clinicopathologic features of surgically resected primary gastric lymphoma.

Authors:  Seong-Ho Kong; Min-A Kim; Do-Joong Park; Hyuk-Joon Lee; Hye-Seung Lee; Chul-Woo Kim; Han-Kwang Yang; Dae-Seog Heo; Kuhn-Uk Lee; Kuk-Jin Choe
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

Review 4.  Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management.

Authors:  M-Q Du; J C Atherton
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

Review 5.  Current status of gastric MALT lymphoma.

Authors:  T Wündisch; M Stolte
Journal:  Curr Gastroenterol Rep       Date:  2006-10

Review 6.  Consequences of Helicobacter pylori infection in children.

Authors:  Lucia Pacifico; Caterina Anania; John F Osborn; Flavia Ferraro; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

7.  Secondary mucosa-associated lymphoid tissue (MALT) lymphoma of the colon.

Authors:  Shagufta Shaheen; Achuta K Guddati
Journal:  Med Oncol       Date:  2013-02-20       Impact factor: 3.064

8.  Helicobacter suis causes severe gastric pathology in mouse and mongolian gerbil models of human gastric disease.

Authors:  Bram Flahou; Freddy Haesebrouck; Frank Pasmans; Katharina D'Herde; Ann Driessen; Kim Van Deun; Annemieke Smet; Luc Duchateau; Koen Chiers; Richard Ducatelle
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

9.  Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial.

Authors:  Barry W Hancock; Wendi Qian; David Linch; Jean-Charles Delchier; Paul Smith; Ira Jakupovic; Cathy Burton; Robert Souhami; Andrew Wotherspoon; Christiane Copie-Bergman; Carlo Capella; Catherine Traulle; Michael Levy; Sergio Cortelazzo; Andres J M Ferreri; Achille Ambrosetti; Graziella Pinotti; Giovanni Martinelli; Umberto Vitolo; Franco Cavalli; Christian Gisselbrecht; Emanuele Zucca
Journal:  Br J Haematol       Date:  2008-11-22       Impact factor: 6.998

10.  Disease association with two Helicobacter pylori duplicate outer membrane protein genes, homB and homA.

Authors:  Monica Oleastro; Rita Cordeiro; Yoshio Yamaoka; Dulciene Queiroz; Francis Mégraud; Lurdes Monteiro; Armelle Ménard
Journal:  Gut Pathog       Date:  2009-06-22       Impact factor: 4.181
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.